Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Update of PNU-145156E phase I trial presented at ASCO meeting

May 27, 1999

Techniclone initiates phase I/II trial of TNT for solid tumors, reports phase I brain cancer results

May 27, 1999

MGI Pharma expands ovarian cancer trial with MGI-114

May 27, 1999

ASCO news: Abgenix presents preclinical pharmacological profile of fully human anti-EGF MAb

May 26, 1999

Cancer vaccine induces disease stabilization and is well tolerated in ongoing early clinical trials

May 26, 1999

Joint effort at Zeneca and Isis results in preparation of TS mRNA-targeting ODNs

May 26, 1999

BPHA: a potent and selective MMP inhibitor in early development at Shionogi

May 26, 1999

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

May 25, 1999

SkyePharma announces U.S. launch of DepoCyt

May 25, 1999

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...